CYTOKINETICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cytokinetics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Cytokinetics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$141M, a 15.2% decline year-over-year.
  • Cytokinetics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$525M, a 5.81% decline year-over-year.
  • Cytokinetics Inc annual Operating Income (Loss) for 2023 was -$496M, a 53.1% decline from 2022.
  • Cytokinetics Inc annual Operating Income (Loss) for 2022 was -$324M, a 74% decline from 2021.
  • Cytokinetics Inc annual Operating Income (Loss) for 2021 was -$186M, a 98.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$525M -$141M -$18.5M -15.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$506M -$130M -$8.12M -6.66% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$498M -$126M -$1.76M -1.42% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$496M -$127M -$388K -0.31% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$496M -$122M -$13.8M -12.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$482M -$122M -$111M -1022% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$371M -$124M -$46.6M -59.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$324M -$127M -$105M -485% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$219M -$108M -$39.2M -56.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$180M -$10.9M +$43.9M +80.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$224M -$77.9M -$37.2M -91.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$186M -$21.7M +$14.7M +40.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$201M -$69.2M -$74.4M -1435% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$127M -$54.8M -$22.4M -69.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$104M -$40.6M -$10.2M -33.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$93.9M -$36.4M -$12.7M -53.6% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 -$81.2M $5.18M +$29.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$110M -$32.4M -$5.64M -21.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$105M -$30.4M -$5.84M -23.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$98.9M -$23.7M -$2.25M -10.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$96.6M -$23.9M -$6.01M -33.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$90.6M -$26.7M -$3.3M -14.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$87.3M -$24.5M +$1.61M +6.17% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$88.9M -$21.5M +$15.1M +41.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$104M -$17.9M +$10.5M +37% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 -$114M -$23.4M +$1.78M +7.07% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$116M -$26.1M -$2.88M -12.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$113M -$36.5M -$44.2M -575% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$69.2M -$28.4M -$62.4M -184% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$6.79M -$25.2M -$14.2M -129% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $7.39M -$23.3M -$11.3M -94.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $18.7M $7.69M +$16.7M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $1.98M $34M +$42.9M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 -$40.9M -$11M -$422K -3.99% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$40.5M -$12M -$3.05M -34.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$37.4M -$9.02M -$17.4M -207% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 -$20M -$8.89M -$2.89M -48.2% Jul 1, 2015 Sep 30, 2015 10-Q/A 2016-12-15
Q2 2015 -$17.1M -$10.6M -$2.18M -26% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$14.9M -$8.91M -$139K -1.59% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$14.8M $8.42M +$1.99M +30.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 -$16.7M -$6M +$6.61M +52.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$23.4M -$8.41M +$6.66M +44.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$30M -$8.77M +$3.88M +30.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-04
Q4 2013 -$33.9M $6.43M +$17.9M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-03
Q3 2013 -$51.8M -$12.6M -$2.54M -25.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$49.3M -$15.1M -$6.11M -68.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$43.2M -$12.6M -$2.71M -27.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 -$40.5M -$11.5M +$409K +3.44% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-06
Q3 2012 -$40.9M -$10.1M +$595K +5.58% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-06
Q2 2012 -$41.5M -$8.96M +$4.69M +34.4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 -$46.2M -$9.94M +$1.81M +15.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$48M -$11.9M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-07
Q3 2011 -$10.7M +$1.9M +15.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$13.6M -$493K -3.75% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-06
Q1 2011 -$11.8M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$12.6M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$13.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.